发明名称 |
METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS |
摘要 |
In some aspects, the invention provides methods of treating a subject in need of treatment for a chronic complement-mediated disorder. In some aspects, the invention provides methods of treating a subject in need of treatment for a Th17-associated disorder. In some aspects, the invention provides methods of treating a subject in need of treatment for a chronic respiratory system disorder. In some aspects, the invention provides methods of administering a complement inhibitor to a subject. In some embodiments, a method of treating a subject comprises administering multiple doses of a complement inhibitor to the subject according to a dosing schedule that leverages the prolonged effect of complement inhibition in chronic respiratory disorders. In some embodiments, a subject has chronic obstructive pulmonary disease. In some embodiments, a subject has asthma. |
申请公布号 |
US2014371133(A1) |
申请公布日期 |
2014.12.18 |
申请号 |
US201214128447 |
申请日期 |
2012.06.22 |
申请人 |
Francois Cedric;Deschatelets Pascal |
发明人 |
Francois Cedric;Deschatelets Pascal |
分类号 |
A61K38/12;G01N33/68 |
主分类号 |
A61K38/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a subject in need of treatment for a chronic respiratory disorder or other chronic complement-mediated disorder, the method comprising administering multiple doses of a complement inhibitor to the subject according to a dosing schedule in which successive doses are administered on average (i) at least 2 weeks after the plasma concentration of the complement inhibitor decreases to no more than 20% of the maximum plasma concentration that was reached after the previous dose; (ii) at least 2 weeks after plasma complement activation capacity has returned to at least 50% of baseline after the previous dose; (iii) at intervals equal to at least 2 times the terminal plasma half-life of the complement inhibitor; or (iv) at intervals at least 3 weeks apart. |
地址 |
Louisville KY US |